Focus for BIO 2008
Virionyx is looking to partner two programmes:
- Passive immunotherapeutic for HIV/AIDS which has mechanism distinct from existing anti-virals
- Microparticle immune stimulator – a potent activator of both innate and adaptive immune responses
